Virginie Gressin
Overview
Explore the profile of Virginie Gressin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
2090
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skoro-Sajer N, Sheares K, Forfia P, Heresi G, Jevnikar M, Kopec G, et al.
Pulm Circ
. 2024 Jul;
14(2):e12406.
PMID: 38947169
Advances in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) over the past decade changed the disease landscape, yet global insight on clinical practices remains limited. The CTEPH global cross-sectional...
2.
Kopec G, Forfia P, Abe K, Beaudet A, Gressin V, Jevnikar M, et al.
Pulm Circ
. 2024 Feb;
14(1):e12330.
PMID: 38384932
Early recognition and diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is crucial for improving prognosis and reducing the disease burden. Established clinical practice guidelines describe interventions for the diagnosis and...
3.
Jansa P, Ambroz D, Aschermann M, Cerny V, Dytrych V, Heller S, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373865
Error in Figure [...].
4.
Jansa P, Ambroz D, Aschermann M, Cerny V, Dytrych V, Heller S, et al.
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294508
This analysis investigated the prognostic value of hospitalisation in chronic thromboembolic pulmonary hypertension (CTEPH) using data from the Czech Republic, wherein pulmonary endarterectomy (PEA) was the only targeted treatment option...
5.
Jansa P, Ambroz D, Kuhn M, Dytrych V, Aschermann M, Cerny V, et al.
Pulm Circ
. 2022 May;
12(1):e12038.
PMID: 35506113
This study investigated the epidemiology and survival outcomes of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic, wherein pulmonary endarterectomy (PEA) surgery was the only targeted treatment option until...
6.
Sitbon O, Cottin V, Canuet M, Clerson P, Gressin V, Perchenet L, et al.
Eur Respir J
. 2020 May;
56(3).
PMID: 32350101
No abstract available.
7.
Mouthon L, Carpentier P, Lok C, Clerson P, Gressin V, Hachulla E, et al.
Semin Arthritis Rheum
. 2017 Feb;
46(6):759-766.
PMID: 28214014
Objectives: Ischemic digital ulcers (DU) represent a major complication of systemic sclerosis (SSc). We investigated the impact of controlling the ulcerative disease on disability, pain, and quality of life in...
8.
Amedro P, Basquin A, Gressin V, Clerson P, Jais X, Thambo J, et al.
Cardiol Young
. 2016 Mar;
26(7):1250-9.
PMID: 26980152
Background: The aim of this study was to assess health-related quality of life in patients with pulmonary arterial hypertension associated with CHD and correlations with clinical status. Methods: This prospective...
9.
Sitbon O, Benza R, Badesch D, Barst R, Elliott C, Gressin V, et al.
Eur Respir J
. 2015 Apr;
46(1):152-64.
PMID: 25837032
The French Pulmonary Hypertension Network (FPHN) registry and the Registry to Evaluate Early And Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL) have developed predictive models for survival in pulmonary arterial...
10.
Mouthon L, Carpentier P, Lok C, Clerson P, Gressin V, Hachulla E, et al.
J Rheumatol
. 2014 Jun;
41(7):1317-23.
PMID: 24931950
Objective: Ischemic digital ulcers (DU) are frequent and severe complications of systemic sclerosis (SSc). The purpose of our study was to assess the effect of DU on hand disability and...